Motivation and Hesitancies in Obtaining the COVID-19 Vaccine-A Cross-Sectional Study in Norway, USA, UK, and Australia

Overview

Journal Vaccines (Basel)

Date 2023 Jun 28

PMID 37376475

Authors

Janni Leung

Daicia Price

Caitlin McClure-Thomas

Tore Bonsaksen

Mary Ruffolo

Isaac Kabelenga

Gary Lamph

Amy Ostertun Geirdal

Affiliations

Soon will be listed here.

Abstract

Background: Vaccinations protect the public against serious diseases or death; however, some individuals are hesitant in obtaining them. We aim to contribute to the understanding of the challenges of vaccination roll-out by examining the motivations, hesitancies, and their associated factors, in obtaining the COVID-19 vaccines two years into the pandemic.

Methods: Cross-sectional online surveys were conducted in Norway, the USA, the UK, and Australia (N = 1649). The participants self-reported whether they had obtained one of the COVID-19 vaccines. Those who had obtained a vaccine reported the reason for their motivation, and those who had not obtained a vaccine reported the reason for their hesitancies.

Results: More than 80% of the total sample obtained a COVID-19 vaccine because of public health recommendations and trusted that it was safe. Among those who had not obtained one, the most frequent reason was concerns about side effects. Most who obtained the vaccine reported that they believed in science, but many of those who had not obtained one reported distrust. Among those who had not obtained a vaccine, reports of distrust in policies and science were frequent. Concerns about side effects were more common in males and those with lower education, and those living in rural or remote areas.

Conclusion: People who endorsed the vaccine believed that the vaccine reduces the risk of illness, protects the health of others, and had trust in scientific vaccination research. Conversely, the most frequent reason for vaccine hesitancy was concerns about side effects, followed by distrust in healthcare and science. These findings could inform public health strategies that aim to increase vaccination rates.

Citing Articles

The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012-2023).

Aguinaga-Ontoso I, Guillen-Aguinaga S, Guillen-Aguinaga L, Alas-Brun R, Guillen-Aguinaga M, Onambele L Vaccines (Basel). 2025; 13(1).

PMID: 39852785 PMC: 11768563. DOI: 10.3390/vaccines13010006.

Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy.

Ittefaq M, Vu H, Zain A, Ramazan T, Kreps G Hum Vaccin Immunother. 2024; 20(1):2437921.

PMID: 39687950 PMC: 11654708. DOI: 10.1080/21645515.2024.2437921.

Factors Influencing COVID-19 Vaccine Confidence and Uptake in Australian Adults.

Williams C, Saini B, Zaidi S, Kali C, Moujalli G, Castelino R Vaccines (Basel). 2024; 12(6).

PMID: 38932356 PMC: 11209045. DOI: 10.3390/vaccines12060627.

Unveiling Vaccine Hesitancy on Twitter: Analyzing Trends and Reasons during the Emergence of COVID-19 Delta and Omicron Variants.

Cotfas L, Craciun L, Delcea C, Florescu M, Kovacs E, Molanescu A Vaccines (Basel). 2023; 11(8).

PMID: 37631949 PMC: 10458131. DOI: 10.3390/vaccines11081381.

References

Robertson E, Reeve K, Niedzwiedz C, Moore J, Blake M, Green M . Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021; 94:41-50. PMC: 7946541. DOI: 10.1016/j.bbi.2021.03.008. View

Bonsaksen T, Ruffolo M, Price D, Leung J, Thygesen H, Lamph G . Associations between social media use and loneliness in a cross-national population: do motives for social media use matter?. Health Psychol Behav Med. 2023; 11(1):2158089. PMC: 9817115. DOI: 10.1080/21642850.2022.2158089. View

Latkin C, Dayton L, Yi G, Konstantopoulos A, Boodram B . Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021; 270:113684. PMC: 7834519. DOI: 10.1016/j.socscimed.2021.113684. View

Wang K, Wong E, Ho K, Cheung A, Yau P, Dong D . Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys. Vaccines (Basel). 2021; 9(1). PMC: 7832291. DOI: 10.3390/vaccines9010062. View

Crane M, Faden R, Romley J . Disparities In County COVID-19 Vaccination Rates Linked To Disadvantage And Hesitancy. Health Aff (Millwood). 2021; 40(11):1792-1796. DOI: 10.1377/hlthaff.2021.01092. View

Shacham M, Hamama-Raz Y, Ben-Ezra M, Levin Y . Association between COVID-19 and Seasonal Influenza Vaccines to Vaccine Hesitancy, Intolerance of Uncertainty and Mental Health. Vaccines (Basel). 2023; 11(2). PMC: 9959542. DOI: 10.3390/vaccines11020403. View

Ballantyne A, Ganguli-Mitra A . To What Extent Are Calls for Greater Minority Representation in COVID Vaccine Research Ethically Justified?. Am J Bioeth. 2021; 21(2):99-101. DOI: 10.1080/15265161.2020.1861385. View

King W, Rubinstein M, Reinhart A, Mejia R . Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021. PLoS One. 2021; 16(12):e0260731. PMC: 8691631. DOI: 10.1371/journal.pone.0260731. View

Ostertun Geirdal A, Ruffolo M, Leung J, Thygesen H, Price D, Bonsaksen T . Mental health, quality of life, wellbeing, loneliness and use of social media in a time of social distancing during the COVID-19 outbreak. A cross-country comparative study. J Ment Health. 2021; 30(2):148-155. DOI: 10.1080/09638237.2021.1875413. View

10.

Gori D, Capodici A, La Fauci G, Montalti M, Salussolia A, Solda G . COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy. Vaccines (Basel). 2023; 11(4). PMC: 10141216. DOI: 10.3390/vaccines11040839. View

11.

Wise J . Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021; 372:n699. DOI: 10.1136/bmj.n699. View

12.

Dror A, Eisenbach N, Taiber S, Morozov N, Mizrachi M, Zigron A . Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35(8):775-779. PMC: 8851308. DOI: 10.1007/s10654-020-00671-y. View

13.

Muluneh M, Negash K, Tsegaye S, Abera Y, Tadesse D, Abebe S . COVID-19 Knowledge, Attitudes, and Vaccine Hesitancy in Ethiopia: A Community-Based Cross-Sectional Study. Vaccines (Basel). 2023; 11(4). PMC: 10140841. DOI: 10.3390/vaccines11040774. View

14.

Akbulut S, Boz G, Ozer A, Sahin T, Colak C . Evaluation of the Turkish Population's Perspective on COVID-19 Vaccine Hesitancy and Routine Childhood Vaccine Applications: National Survey Study. Vaccines (Basel). 2023; 11(4). PMC: 10145389. DOI: 10.3390/vaccines11040779. View

15.

Larson H, Jarrett C, Eckersberger E, Smith D, Paterson P . Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014; 32(19):2150-9. DOI: 10.1016/j.vaccine.2014.01.081. View

16.

Lane S, MacDonald N, Marti M, Dumolard L . Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017. Vaccine. 2018; 36(26):3861-3867. PMC: 5999354. DOI: 10.1016/j.vaccine.2018.03.063. View

17.

Ryan J, Malinga T . Interventions for vaccine hesitancy. Curr Opin Immunol. 2021; 71:89-91. DOI: 10.1016/j.coi.2021.05.003. View

18.

Bonsaksen T, Leung J, Price D, Ruffolo M, Lamph G, Kabelenga I . Self-Reported Long COVID in the General Population: Sociodemographic and Health Correlates in a Cross-National Sample. Life (Basel). 2022; 12(6). PMC: 9228837. DOI: 10.3390/life12060901. View

19.

Amjad Z, Maryam I, Munir M, Salman M, Baraka M, Ul Mustafa Z . COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond. Vaccines (Basel). 2023; 11(5). PMC: 10223584. DOI: 10.3390/vaccines11050904. View

20.

Shih S, Wagner A, Masters N, Prosser L, Lu Y, Zikmund-Fisher B . Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States. Front Immunol. 2021; 12:558270. PMC: 8236639. DOI: 10.3389/fimmu.2021.558270. View